DekaBank Deutsche Girozentrale - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$183,000
-33.0%
3,9500.0%0.00%0.0%
Q1 2022$273,000
+3.4%
3,950
+11.3%
0.00%0.0%
Q4 2021$264,000
+36.1%
3,550
+2.9%
0.00%0.0%
Q3 2021$194,000
+30.2%
3,4500.0%0.00%
Q2 2021$149,000
-9.7%
3,4500.0%0.00%
-100.0%
Q1 2021$165,000
+15.4%
3,4500.0%0.00%0.0%
Q4 2020$143,000
-5.9%
3,4500.0%0.00%0.0%
Q3 2020$152,000
-29.0%
3,450
-2.8%
0.00%0.0%
Q3 2019$214,000
-64.0%
3,550
-50.0%
0.00%
-66.7%
Q2 2019$595,000
+50.3%
7,100
+61.4%
0.00%
+50.0%
Q1 2019$396,000
+56.5%
4,400
+23.9%
0.00%0.0%
Q4 2018$253,000
-36.1%
3,550
-19.3%
0.00%0.0%
Q3 2018$396,000
-22.0%
4,400
-2.2%
0.00%
-33.3%
Q2 2018$508,000
+41.9%
4,5000.0%0.00%
+50.0%
Q1 2018$358,000
+95.6%
4,500
-2.2%
0.00%
+100.0%
Q4 2017$183,0000.0%4,6000.0%0.00%0.0%
Q3 2017$183,000
+9.6%
4,6000.0%0.00%0.0%
Q2 2017$167,000
+16.0%
4,6000.0%0.00%0.0%
Q1 2017$144,000
-14.3%
4,600
-8.0%
0.00%
-50.0%
Q4 2016$168,000
-26.3%
5,000
-37.5%
0.00%
-33.3%
Q1 2016$228,000
-28.3%
8,000
-15.8%
0.00%
-25.0%
Q4 2015$318,000
-6.5%
9,500
+1.1%
0.00%0.0%
Q3 2015$340,000
-16.9%
9,400
+3.3%
0.00%
-20.0%
Q2 2015$409,000
+52.0%
9,100
+3.4%
0.01%
+66.7%
Q1 2015$269,0008,8000.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders